Brief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
22/09/2026 07:04
BRIEF-Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit Sept 22 (Reuters) - Disruptive Pharma AB (publ) DPHAR.ST:
AGREES TO SELL GTX PLATFORM TO AURELIA INVEST AB SUBSIDIARY
CONSIDERATION INCLUDES MINOR INITIAL CASH PAYMENT AND FUTURE PERFORMANCE-BASED PAYMENTS
PAYMENTS BASED ON MILESTONES INCLUDING FIRST HUMAN DOSING AND MARKET APPROVAL
Source text: ID:nMFN4kBVzK
Further company coverage: DPHAR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover